Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yuping Tongqiao Pian in persistent allergic rhinitis
CTR20221393Phase 3Completed
- Sponsor
- Yiling Pharmaceutical
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Yupingtongqiao in allergic rhinitis (AR), sponsored by Yiling Pharmaceutical. Started Jun 2022; status: completed.
02
Drugs
Yupingtongqiao
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on CTR20221393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221393.